News

Despite being less than two years old, the orthopaedic trauma research team in UK Healthcare's Department of Orthopaedic Surgery and Sports Medicine is making a tremendous impact that is gaining international recognition.

CLIK provides research training, professional development and a small grant to community leaders who are working to reduce health disparities, with a particular focus on Appalachian counties. The program is offered in Hazard, Kentucky. Applications are due Dec. 18.

Kentucky families know better than most the plague of addiction. But there is hope. There is us.

The Kentucky Cabinet for Economic Development is investing $750,000 to support startups and entrepreneurs in Lexington and Central Kentucky under this initiative.

The project is part of DOE’s Carbon Capture Program, which is developing transformational, step-change, low-cost capture processes and enabling technologies that will maximize the efficiency of our nation's fossil-based power generation infrastructure.

Last week, UK graduate and undergraduate students competed in the final rounds of the inaugural 5-Minute Fast Track Research Competition and the 3-Minute Thesis Competition (3MT), academic competitions that cultivates students’ presentation and research communication skills, and challenges students to describe their research in a short period of time.

On this week’s episode of “Behind the Blue,” UKPR and Marketing‘s Carl Nathe talks with Alexander Vazsonyi, a professor in the Department of Family Sciences.

A multidisciplinary team of UK physicians and researchers will collaborate with additional specialists to develop diagnosis-specific educational materials to address opioid pain management options post-discharge, pain management alternatives to opioids and information on safe opioid use, storage and disposal.

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, announced that University of Kentucky's Matthew Gentry has received the Landis Award for Outstanding Mentorship.

A new Nature Communications study led by University of Kentucky Markey Cancer Center researchers suggests that an enzyme known as Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative breast cancer.